A Wakefield woman who survived cancer will host a showbusiness gala in the city to raise money for the charities that helped ...

Researchers conducting a clinical trial of immunotherapy drugs for people with head and neck squamous cell carcinomas (HNSCCs ...

Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

A patient shares his experience with a squamous cell carcinoma diagnosis, treatment and recovery. It was a Friday afternoon, ...

When diagnosing lung metastases and second primary lung cancer in patients with head and neck cancer, low-dose CT leads to better sensitivity than chest x-ray but does not lead to improved overall ...

The longtime local news meteorologist has been temporarily absent from broadcasts as he manages his health, but he’ll be back ...

Adenocarcinoma grows in the tissue of the prostate gland, but other types of cancer can also start in the prostate or spread ...

Researchers are investigating whether a common cholesterol drug could be repurposed to treat HPV-positive cervical cancer.

Phase 1/2 trial evaluating the proprietary combination to be run under CRADA with the National Cancer InstituteSecondVersamune®platform candidate ...

Single-cell analysis revealed the molecular triggers that drive stem cells to become cancerous, which may help inform ...

Head and neck squamous cell carcinomas responded better to a combination of two immunotherapies than to one immunotherapy ...